MindMed Launches Psychedelic-Based Pain Treatment Project
Mind Medicine Inc. (NEO: MMED), also known as MindMed, announced today that it has launched Project Angie. The project is
Read more
Psychedelics
Bright Minds: The Next Revolution In Mental Health Care – The Daily Dive
Today on the Daily Dive, our host Cassandra Leah sits down with Ian McDonald, CEO of Bright Minds Biosciences (CSE:
Read more
Psyched Wellness Signs Two Year Supply Agreement For Amanita Muscaria
Psyched Wellness (CSE: PSYC) this morning had a brief announcement. Within, the company revealed that it has entered into a
Read more
Champignon Brands To Change Name To Braxia Scientific
Champignon Brands (CSE: SHRM) is evidently looking to turn a new leaf, with the company this morning announcing that it
Read more
Revive Therapeutics Applies For Orphan Drug Designation For Psilocybin
Revive Therapeutics (CSE: RVV) has filed for orphan drug designation with the US Food and Drug Administration. The filing relates
Read more
Bright Minds Expands Leadership, Scientific Advisory Teams
Bright Minds Biosciences (CSE: DRUG) this morning enhanced its leadership team. The company appointed two industry executives to key roles
Read more
PharmaTher Files Patent For Use Of Ketamine In Type 2 Diabetes, Obesity
PharmaTher Holdings (CSE: PHRM) has expanded its patent portfolio. The company this morning announced the filing of a provisional patent
Read more
Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract
Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with
Read more
MindMed To Begin Trading On The Nasdaq April 27
MindMed (NEO: MMED) is moving up to the big leagues. The psychedelics company this morning announced that it has been
Read more
Champignon Brands To Resume Trading Today
Champignon Brands (CSE: SHRM) is expected to resume trading today after what was a nearly year-long trading halt imposed by
Read more